Colorectal Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Colorectal Cancer, including details on symptoms, genetics, screening, treatment, information.

Volume 3 (2006), Issue 4 (April)

1. Iron and colorectal cancer risk in the alpha-tocopherol, beta-carotene cancer prevention study.
   Int J Cancer, 118(12): 3147-52. [Abstract] [Full-text]
2. Prognostic impact of orotate phosphoribosyl transferase among 5-fluorouracil metabolic enzymes in resectable colorectal cancers treated by oral 5-fluorouracil-based adjuvant chemotherapy.
   Int J Cancer, 118(12): 3084-8. [Abstract] [Full-text]
3. New immunochemical fecal occult blood test with two-consecutive stool sample testing is a cost-effective approach for colon cancer screening: results of a prospective multicenter study in Chinese patients.
   Int J Cancer, 118(12): 3078-83. [Abstract] [Full-text]
4. Regional hypermethylation and global hypomethylation are associated with altered chromatin conformation and histone acetylation in colorectal cancer.
   Int J Cancer, 118(12): 2999-3005. [Abstract] [Full-text]
5. Associations between vitamin D, vitamin D receptor gene and the androgen receptor gene with colon and rectal cancer.
   Int J Cancer, 118(12): 3140-6. [Abstract] [Full-text]
6. Prognostic impact of hematogenous tumor cell dissemination in patients with stage II colorectal cancer.
   Int J Cancer, 118(12): 3072-7. [Abstract] [Full-text]
7. Dietary administration with prenyloxycoumarins, auraptene and collinin, inhibits colitis-related colon carcinogenesis in mice.
   Int J Cancer, 118(12): 2936-42. [Abstract] [Full-text]
8. Multiplex tetra-primer amplification refractory mutation system PCR to detect 6 common germline mutations of the MUTYH gene associated with polyposis and colorectal cancer.
   Clin Chem, 52(4): 739-43. [Abstract] [Full-text]
9. Lack of chemopreventive effects of ginger on colon carcinogenesis induced by 1,2-dimethylhydrazine in rats.
   Food Chem Toxicol, 44(6): 877-84. [Abstract] [Full-text]
10. Apoptotic effect of red wine polyphenols on human colon cancer SNU-C4 cells.
    Food Chem Toxicol, 44(6): 898-902. [Abstract] [Full-text]
11. XELOX (capecitabine plus oxaliplatin) as first-line treatment for elderly patients over 70 years of age with advanced colorectal cancer.
    Br J Cancer, 94(7): 969-75. [Abstract] [Full-text]
12. A phase II study of fixed-dose capecitabine and assessment of predictors of toxicity in patients with advanced/metastatic colorectal cancer.
    Br J Cancer, 94(7): 964-8. [Abstract] [Full-text]
13. Concurrent chemoradiation with capecitabine and weekly irinotecan as preoperative treatment for rectal cancer: results from a phase I/II study.
    Br J Cancer, 94(7): 976-81. [Abstract] [Full-text]
14. Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies.
    Br J Cancer, 94(7): 982-99. [Abstract] [Full-text]
15. Mortality from all cancers and lung, colorectal, breast and prostate cancer by country of birth in England and Wales, 2001-2003.
    Br J Cancer, 94(7): 1079-85. [Abstract] [Full-text]
16. CDX2 has tumorigenic potential in the human colon cancer cell lines LOVO and SW48.
    Oncogene, 25(15): 2264-72. [Abstract] [Full-text]
17. Colorectal cancer in Hispanics: a population at risk for earlier onset, advanced disease, and decreased survival.
    Am J Clin Oncol, 29(2): 123-6. [Abstract] [Full-text]
18. Phase I/pilot study of SU5416 (semaxinib) in combination with irinotecan/bolus 5-FU/LV (IFL) in patients with metastatic colorectal cancer.
    Am J Clin Oncol, 29(2): 109-15. [Abstract] [Full-text]
19. Identification of acromegalic patients at risk of developing colonic adenomas.
    J Clin Endocrinol Metab, 91(4): 1351-6. [Abstract] [Full-text]
20. Methylenetetrahydrofolate reductase gene polymorphisms: genomic predictors of clinical response to fluoropyrimidine-based chemotherapy?
    Cancer Chemother Pharmacol, 57(6): 835-40. [Abstract] [Full-text]
21. Biomarkers for assessment of pharmacologic activity for a vascular endothelial growth factor (VEGF) receptor inhibitor, PTK787/ZK 222584 (PTK/ZK): translation of biological activity in a mouse melanoma metastasis model to phase I studies in patients with advanced colorectal cancer with liver metastases.
    Cancer Chemother Pharmacol, 57(6): 761-71. [Abstract] [Full-text]
22. Green tea polyphenol (-)-epigallocatechin-3-gallate inhibits cyclooxygenase-2 expression in colon carcinogenesis.
    Mol Carcinog, 45(5): 309-19. [Abstract] [Full-text]
23. Comparison of two antibodies for immunohistochemical evaluation of epidermal growth factor receptor expression in colorectal carcinomas, adenomas, and normal mucosa.
    Cancer, 106(8): 1857-62. [Abstract] [Full-text]
24. Is T classification still correlated with lymph node status after preoperative chemoradiotherapy for rectal cancer?
    Cancer, 106(8): 1694-700. [Abstract] [Full-text]
25. Epithelial and stromal genetic instability contributes to genesis of colorectal adenomas.
    Gut, 55(5): 695-702. [Abstract] [Full-text]
26. Elevated anal squamous cell carcinoma risk associated with benign inflammatory anal lesions.
    Gut, 55(5): 703-7. [Abstract] [Full-text]
27. Physical activity, insulin-like growth factor 1, insulin-like growth factor binding protein 3, and survival from colorectal cancer.
    Gut, 55(5): 689-94. [Abstract] [Full-text]
28. Survival benefit of high ligation of the inferior mesenteric artery in sigmoid colon or rectal cancer surgery.
    Br J Surg, 93(5): 609-15. [Abstract] [Full-text]
29. Molecular biology of squamous cell carcinoma of the anus.
    Br J Surg, 93(5): 531-8. [Abstract] [Full-text]
30. Downstaging colorectal liver metastases by concomitant unilateral portal vein ligation and selective intra-arterial chemotherapy.
    Br J Surg, 93(5): 587-92. [Abstract] [Full-text]
31. Short interfering RNA-mediated gene silencing of vascular endothelial growth factor: effects on cellular proliferation in colon cancer cells.
    Arch Surg, 141(4): 367-74; discussion 374. [Abstract] [Full-text]
32. Hypoxia in human colorectal adenocarcinoma: comparison between extrinsic and potential intrinsic hypoxia markers.
    Int J Radiat Oncol Biol Phys, 65(1): 246-54. [Abstract] [Full-text]
33. Distal intramural spread of rectal cancer after preoperative radiotherapy: the results of a multicenter randomized clinical study.
    Int J Radiat Oncol Biol Phys, 65(1): 182-8. [Abstract] [Full-text]
34. Chemokine receptor CCR6 expression level and liver metastases in colorectal cancer.
    J Clin Oncol, 24(12): 1910-6. [Abstract] [Full-text]
35. Phase II study of capecitabine, oxaliplatin, and erlotinib in previously treated patients with metastastic colorectal cancer.
    J Clin Oncol, 24(12): 1892-7. [Abstract] [Full-text]
36. The risk of developing metastatic disease in colorectal cancer is related to CD105-positive vessel count.
    J Surg Oncol, 93(6): 446-55. [Abstract] [Full-text]
37. Metastasis-associated protein S100A4--a potential prognostic marker for colorectal cancer.
    J Surg Oncol, 93(6): 498-503. [Abstract] [Full-text]
38. Lymph node counts, rates of positive lymph nodes, and patient survival for colon cancer surgery in Ontario, Canada: a population-based study.
    J Surg Oncol, 93(6): 439-45. [Abstract] [Full-text]
39. Allogeneic nonmyeloablative hematopoietic cell transplantation in metastatic colon cancer: tumor-specific T cells directed to a tumor-associated antigen are generated in vivo during GVHD.
    Blood, 107(9): 3795-803. [Abstract] [Full-text]
40. 5-Fluorouracil dose escalation enabled with PN401 (triacetyluridine): toxicity reduction and increased antitumor activity in mice.
    Cancer Chemother Pharmacol, 58(1): 136-42. [Abstract] [Full-text]
41. Patient preferences and adherence to colorectal cancer screening in an urban population.
    Am J Public Health, 96(5): 809-11. [Abstract] [Full-text]
42. Truncated APC is required for cell proliferation and DNA replication.
    Int J Cancer, 119(1): 74-9. [Abstract] [Full-text]
43. Clinicopathological characteristics of colorectal cancers with loss of imprinting of insulin-like growth factor 2.
    Int J Cancer, 119(1): 80-3. [Abstract] [Full-text]
44. Surgery of metastatic anal sac adenocarcinoma in five dogs.
    Vet Surg, 35(3): 267-70. [Abstract] [Full-text]
45. Treatment of hepatic metastases from colorectal cancer: many doubts, some certainties.
    Cancer Treat Rev, 32(3): 214-28. [Abstract] [Full-text]
46. Multi-level gene expression profiles affected by thymidylate synthase and 5-fluorouracil in colon cancer.
    BMC Genomics, 7: 68. [Abstract] [Full-text]
47. Interleukin-6 trans-signalling in chronic inflammation and cancer.
    Scand J Immunol, 63(5): 321-9. [Abstract] [Full-text]

© 2004-2008 Colorectal Cancer Research Today. All Rights Reserved.